SGLT2 Inhibitors and Euglycemic Ketoacidosis.

Masuta, Pardeep

SGLT2 Inhibitors and Euglycemic Ketoacidosis. [electronic resource] - American journal of therapeutics - e498-e500 p. digital

Publication Type: Case Reports; Letter

1536-3686

10.1097/MJT.0000000000000587 doi


Blood Glucose--analysis
Canagliflozin--adverse effects
Diabetes Mellitus, Type 2--blood
Diabetic Ketoacidosis--blood
Female
Glucose--administration & dosage
Humans
Insulin--therapeutic use
Middle Aged
Sodium-Glucose Transporter 2 Inhibitors--adverse effects